» Articles » PMID: 28967557

Combining Constitutively Active Rheb Expression and Chondroitinase Promotes Functional Axonal Regeneration After Cervical Spinal Cord Injury

Overview
Journal Mol Ther
Publisher Cell Press
Date 2017 Oct 3
PMID 28967557
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

After spinal cord injury (SCI), severed axons in the adult mammalian CNS are unable to mount a robust regenerative response. In addition, the glial scar at the lesion site further restricts the regenerative potential of axons. We hypothesized that a combinatorial approach coincidentally targeting these obstacles would promote axonal regeneration. We combined (1) transplantation of a growth-permissive peripheral nerve graft (PNG) into an incomplete, cervical lesion cavity; (2) transduction of neurons rostral to the SCI site to express constitutively active Rheb (caRheb; a Ras homolog enriched in brain), a GTPase that directly activates the growth-promoting pathway mammalian target of rapamycin (mTOR) via AAV-caRheb injection; and (3) digestion of growth-inhibitory chondroitin sulfate proteoglycans within the glial scar at the distal PNG interface using the bacterial enzyme chondroitinase ABC (ChABC). We found that expressing caRheb in neurons post-SCI results in modestly yet significantly more axons regenerating across a ChABC-treated distal graft interface into caudal spinal cord than either treatment alone. Excitingly, we found that caRheb+ChABC treatment significantly potentiates the formation of synapses in the host spinal cord and improves the animals' ability to use the affected forelimb. Thus, this combination strategy enhances functional axonal regeneration following a cervical SCI.

Citing Articles

Axonal growth inhibitors and their receptors in spinal cord injury: from biology to clinical translation.

Sousa Chambel S, Cruz C Neural Regen Res. 2023; 18(12):2573-2581.

PMID: 37449592 PMC: 10358698. DOI: 10.4103/1673-5374.373674.


Bridging the gap of axonal regeneration in the central nervous system: A state of the art review on central axonal regeneration.

Costa G, Ribeiro F, Sebastiao A, Muir E, Vaz S Front Neurosci. 2022; 16:1003145.

PMID: 36440273 PMC: 9682039. DOI: 10.3389/fnins.2022.1003145.


Progression in translational research on spinal cord injury based on microenvironment imbalance.

Fan B, Wei Z, Feng S Bone Res. 2022; 10(1):35.

PMID: 35396505 PMC: 8993811. DOI: 10.1038/s41413-022-00199-9.


Progesterone attenuates neurological deficits and exerts a protective effect on damaged axons via the PI3K/AKT/mTOR-dependent pathway in a mouse model of intracerebral hemorrhage.

Liu C, Gao W, Zhao L, Cao Y Aging (Albany NY). 2022; 14(6):2574-2589.

PMID: 35305084 PMC: 9004566. DOI: 10.18632/aging.203954.


Co-targeting myelin inhibitors and CSPGs markedly enhances regeneration of GDNF-stimulated, but not conditioning-lesioned, sensory axons into the spinal cord.

Zhai J, Kim H, Han S, Manire M, Yoo R, Pang S Elife. 2021; 10.

PMID: 33942723 PMC: 8139830. DOI: 10.7554/eLife.63050.


References
1.
Courtine G, Song B, Roy R, Zhong H, Herrmann J, Ao Y . Recovery of supraspinal control of stepping via indirect propriospinal relay connections after spinal cord injury. Nat Med. 2007; 14(1):69-74. PMC: 2916740. DOI: 10.1038/nm1682. View

2.
Shen Y, Tenney A, Busch S, Horn K, Cuascut F, Liu K . PTPsigma is a receptor for chondroitin sulfate proteoglycan, an inhibitor of neural regeneration. Science. 2009; 326(5952):592-6. PMC: 2811318. DOI: 10.1126/science.1178310. View

3.
Duran R, Hall M . Regulation of TOR by small GTPases. EMBO Rep. 2012; 13(2):121-8. PMC: 3271343. DOI: 10.1038/embor.2011.257. View

4.
Lemons M, Howland D, Anderson D . Chondroitin sulfate proteoglycan immunoreactivity increases following spinal cord injury and transplantation. Exp Neurol. 2000; 160(1):51-65. DOI: 10.1006/exnr.1999.7184. View

5.
Kauwe G, Tsurudome K, Penney J, Mori M, Gray L, Calderon M . Acute Fasting Regulates Retrograde Synaptic Enhancement through a 4E-BP-Dependent Mechanism. Neuron. 2016; 92(6):1204-1212. PMC: 5797711. DOI: 10.1016/j.neuron.2016.10.063. View